Breaking News

Emergent BioSolutions Wins $63M BARDA Contract

Will develop treatment for cyanide exposure together with Southwest Research Institute

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Emergent BioSolutions has been awarded a contract valued at approximately $63 million by the Biomedical Advanced Research and Development Authority (BARDA) to develop an antidote spray device for the treatment of known or suspected acute cyanide poisoning. The single-use intranasal spray device will deliver a stabilized form of isoamyl nitrite (SIAN) and is intended for use by first responders and medical personnel following a cyanide incident. “Emergent has a successful history of developing...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters